RIPK2 and cancer: From the lncRNA-mRNA pathway network, PYCARD, RIPK2, and CASP1 were found to be significantly enriched in the NOD-like receptor signaling pathway, whereas MAP2K2, LUM, RPS6, PDCD4, TWIST1, and HIF1A were significantly enriched in proteoglycans in cancers.